Chorionic Villous Sampling
Introduction
Chorionic villous sampling is a prenatal diagnostic procedure performed to obtain a small sample of placental tissue for genetic and chromosomal analysis during early pregnancy. The chorionic villi are tiny finger-like projections of placental tissue that share the same genetic makeup as the developing fetus, making them an ideal source of material for prenatal diagnosis. Performed under continuous real-time imaging guidance, chorionic villous sampling allows clinicians to obtain a definitive chromosomal or genetic diagnosis earlier in pregnancy than any other invasive prenatal test. This early diagnostic window is one of its most significant advantages, giving expectant parents and their clinical team critical information at a stage in pregnancy when management options remain broadest. It is a cornerstone procedure in the field of fetal medicine and prenatal diagnosis, combining precision technique with profound clinical impact.
Understanding Chorionic Villi and Their Diagnostic Significance
The placenta begins developing in the earliest weeks of pregnancy from trophoblastic cells that form the outer layer of the fertilized embryo. The chorionic villi are microscopic projections of this placental tissue that invade the uterine lining and establish the maternal-fetal interface through which oxygen and nutrients are exchanged. Because the chorionic villi are derived from the same fertilized egg as the fetus, they carry an identical chromosomal and genetic profile. A sample of chorionic villous tissue can therefore be used to prepare a full chromosomal karyotype, perform chromosomal microarray analysis, carry out fluorescence in situ hybridization studies for rapid detection of common aneuploidies and conduct targeted molecular genetic testing for specific single gene disorders. This makes chorionic villous sampling one of the most powerful diagnostic tools available in prenatal medicine, capable of detecting a vast range of chromosomal and genetic conditions from a very early gestational age.
Indications for the Procedure
Chorionic villous sampling is indicated in pregnancies where there is a significant risk of fetal chromosomal or genetic abnormality and where early diagnosis is either clinically important or desired by the patient. Common indications include advanced maternal age, where the risk of chromosomal conditions such as trisomy 21, trisomy 18 and trisomy 13 is elevated. It is also indicated when first trimester screening, including nuchal translucency measurement and maternal serum biochemistry, has returned a high-risk result or when non-invasive prenatal testing using cell-free fetal DNA has identified a high-risk result requiring confirmation with a diagnostic test. A known family history of a specific chromosomal disorder, a previous affected pregnancy or one partner being a known carrier of a significant genetic condition are all established indications. Detection of structural fetal anomalies on first trimester ultrasound may also prompt early invasive testing. Patients who require an early definitive diagnosis for personal, psychological or cultural reasons may also be offered chorionic villous sampling in preference to the later amniocentesis.
Timing and Gestational Window
Chorionic villous sampling is typically performed between ten and thirteen weeks of gestation. This timing is important for several reasons. Before ten weeks, the procedure carries a higher risk of fetal limb reduction defects due to vascular disruption at a critical stage of fetal development and the placental tissue may be insufficient for reliable sampling. After thirteen weeks, the changing anatomy of the uterus and placenta makes the procedure technically more challenging and amniocentesis becomes the preferred alternative for invasive prenatal diagnosis. The ten to thirteen week window therefore represents the optimal period for safe and effective sampling.
Pre-Procedure Preparation
Before the procedure, the patient undergoes a detailed consultation with a fetal medicine specialist or obstetrician, supported where appropriate by a genetic counselor. The purpose of the test, its diagnostic capabilities and limitations, the technique and the associated risks are discussed comprehensively. A pre-procedure ultrasound examination is performed to confirm fetal viability, assess gestational age, determine the location and extent of the placenta and identify the most accessible and thickest portion of placental tissue suitable for sampling. The position of the uterus, the placental site whether anterior, posterior, fundal or lateral and the relationship of the access route to the bladder and bowel are all carefully assessed to determine whether a transabdominal or transcervical approach is most appropriate. Blood group and rhesus status are confirmed and anti-D immunoglobulin is administered to rhesus-negative patients following the procedure to prevent sensitization.
How the Procedure is Performed
Chorionic villous sampling can be performed via two routes depending on placental location and uterine position. The transabdominal approach is most commonly used when the placenta is located anteriorly or fundally, while the transcervical approach is employed when the placenta is posterior or when the transabdominal route is not feasible.
In the transabdominal approach, the patient lies supine on the procedure table with the abdomen exposed. The skin is cleaned and sterilized. Real-time imaging guidance is used to continuously monitor the uterus, placenta and fetus throughout the procedure. Local anesthetic is administered to the skin and subcutaneous tissues. A needle, typically eighteen to twenty gauge, is advanced under continuous imaging guidance through the abdominal wall and uterine wall and into the thickest accessible portion of the placenta, carefully avoiding the fetus, umbilical cord and amniotic sac. Once the needle tip is confirmed to be correctly positioned within the placental tissue, a syringe containing transport medium is attached and gentle suction is applied while the needle is moved back and forth within the placental substance using short strokes to dislodge and collect chorionic villous tissue. The aspirated material is inspected to confirm the presence of adequate villous tissue before the needle is withdrawn.
In the transcervical approach, the patient is positioned as for a pelvic examination. A speculum is inserted, the cervix is cleaned and a flexible catheter is advanced through the cervical canal under imaging guidance and directed into the placental substance. Gentle suction is applied to aspirate villous tissue through the catheter. The transcervical route avoids needle passage through the abdominal wall but requires careful technique to minimize the risk of infection and is generally associated with slightly higher rates of procedure-related pregnancy loss compared to the transabdominal approach. Following sample collection by either route, fetal cardiac activity is confirmed on imaging before the patient is discharged.
Post-Procedure Care and Recovery
Patients are observed for thirty to sixty minutes following the procedure and are discharged home the same day in the absence of complications. Mild uterine cramping and light vaginal spotting are common in the hours following the procedure and typically resolve without intervention. Patients are advised to rest for the remainder of the day, avoid strenuous activity for forty-eight hours and refrain from sexual intercourse for several days. They are instructed to contact their clinical team if they experience heavy vaginal bleeding, significant or persistent cramping, leakage of fluid, fever or reduced fetal movement after an appropriate gestational age. Rapid preliminary results from FISH or microarray analysis are often available within two to three working days, while a full chromosomal karyotype typically takes ten to fourteen days.
Risks and Complications
Chorionic villous sampling carries a small but recognized risk of procedure-related pregnancy loss, quoted at approximately one in one hundred to one in two hundred procedures in experienced fetal medicine centers. Other potential complications include vaginal bleeding or spotting, infection, rupture of membranes and rhesus sensitization in rhesus-negative patients. The risk of fetal limb reduction defects is confined to procedures performed before ten weeks of gestation and is not a concern when the procedure is performed within the recommended gestational window. Continuous real-time imaging guidance significantly reduces procedural risks by allowing precise needle or catheter placement and continuous monitoring of fetal wellbeing throughout.
Diagnostic Value and Clinical Impact
The diagnostic information provided by chorionic villous sampling can be life-changing for expectant parents. An early definitive diagnosis of a chromosomal or genetic condition allows families to make informed decisions about the pregnancy, access appropriate specialist counseling, prepare for the birth of a child with a specific condition or consider termination of pregnancy at an earlier gestational age when that option is available. A normal result provides profound reassurance to high-risk couples at a stage in pregnancy when anxiety is typically at its peak. The ability to obtain this information in the first trimester rather than waiting until the second trimester for amniocentesis is widely regarded as one of the most important advantages chorionic villous sampling offers.
Conclusion
Chorionic villous sampling performed under real-time imaging guidance is a technically precise and diagnostically powerful procedure that occupies a central role in first trimester prenatal diagnosis. By providing definitive chromosomal and genetic information earlier in pregnancy than any other invasive test, it empowers patients and clinicians with the knowledge needed to make fully informed decisions at the earliest possible stage. In the hands of an experienced fetal medicine team with appropriate imaging guidance and genetic laboratory support, it remains one of the most valuable and impactful procedures available in the care of the high-risk pregnant patient.